I don't think anyone buying DKAM is unaware of dilution, right?
Even a penny player should look at a company's financial statements if they are available. DKAM's dilution is public info. Their last financial statement was very complete and detailed.
If anyone is only basing their investment plays on investorhub boards, they should seek help. You've been here so much longer than me, so you may know some people really do base their decisions on these boards. That's why you provide a service.
My concern is basically if I am getting truthful information from the company so my investment decisions can be based on a level playing field. You know from my posts over the weekend that was not the case at another company. I was frustrated.
Some posters on this board were very helpful and kind. In that company's case just today, at otcmarkets.com an Insider Trading Warning was posted on that companies listing. Most of the people on that board are still pumping and buying. I think that is sad.
So back to DKAM, no one forced the buyers to buy today. They were the ones to set the stock's value. It's either a penny player who gave up, PK or vendors who got less than they wanted.
If it goes down some more, so be it. If it goes to .001 that will put an end to dilution, and you will be bored, but you can have hope ... it could go even lower than that.
But when the revenues are reported, and I expect they will be between $250,000 - $350,000, you will have to get all wound up again, and rev up your message machine.
The only thing, there will be another side of the story unfolding in front of peoples' eyes. Like the facts about dilution that are repeated here and in DKAM's financial statements, the reported revenue numbers won't lie.
